Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.20.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Operating activities    
Net loss $ (24,620) $ (6,169)
Adjustments to reconcile net loss to net cash used in operating activities:    
Share-based compensation 1,506 308
Depreciation 8 3
Non-cash acquired in-process research and development 10,502 0
Gain on note extinguishment (3,672) 0
Non-cash interest on convertible notes 492 252
Non-cash interest on convertible notes - related party 51 42
Non-cash discount amortization on convertible notes 873 1,014
Non-cash discount amortization on convertible notes - related party 71 101
Fair value change in derivative and warrant liabilities 1,486 499
Non-cash interest attributed to Series A warrant issuance 4,671 0
Issuance costs attributed to Series A warrants 689 0
Change in assets and liabilities:    
Prepaid expenses and other assets (906) 58
Accounts payable 792 (168)
Accrued and other liabilities 1,260 467
Net cash used in operating activities (6,797) (3,593)
Investing activities    
Cash acquired in connection with asset acquisition 2,014 0
Transaction costs in connection with asset acquisition (1,475) 0
Purchases of property and equipment 0 (25)
Net cash provided by (used in) investing activities 539 (25)
Financing activities    
Proceeds from pre-merger financing 21,150 0
Proceeds from issuance of convertible notes 2,197 4,383
Proceeds from issuance of convertible notes - related party 0 323
Issuance costs attributed to pre-merger financing (1,769) 0
Issuance costs attributed to convertible notes (10) (2)
Settlement of Rexahn warrants (506) 0
Exercise of stock options 58 0
Net cash provided by financing activities 21,120 4,704
Net increase in cash and cash equivalents 14,862 1,086
Cash and cash equivalents at beginning of period 1,537 451
Cash and cash equivalents at end of period 16,399 1,537
Supplemental disclosure of cash flow information:    
Cash paid for income taxes 0 0
Cash paid for interest 0 0
Supplemental non-cash financing transactions:    
Non-cash conversion of convertible notes to common stock 9,365 0
Common stock and warrants issued in connection with the asset acquisition 8,883 0
Unpaid transaction costs in connection with asset acquisition 100 0
Net assets assumed in connection with asset acquisition 68 0
Bifurcation and modification of premium conversion derivative related to convertible notes 831 1,910
Unpaid deferred offering costs 0 76
Proceeds receivable from convertible note issuance $ 0 $ 125